Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

BACKGROUND: Acute exacerbations contribute to the morbidity and mortality associated with chronic obstructive pulmonary disease (COPD). This proof-of-concept study evaluates whether intermittent pulsed moxifloxacin treatment could reduce the frequency of these exacerbations. METHODS: Stable patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Sanjay, Jones, Paul W, Theron, Marlize Schmitt, Miravitlles, Marc, Rubinstein, Ethan, Wedzicha, Jadwiga A, Wilson, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834642/
https://www.ncbi.nlm.nih.gov/pubmed/20109213
http://dx.doi.org/10.1186/1465-9921-11-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834642/
https://www.ncbi.nlm.nih.gov/pubmed/20109213
http://dx.doi.org/10.1186/1465-9921-11-10

Ejemplares similares